Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

STATE OF WEST VIRGINIA WELCH COMMUNITY HOSPITAL

NPI: 1134158900 · WELCH, WV 24801 · General Acute Care Hospital · NPI assigned 07/02/2006

$4.56M
Total Medicaid Paid
243,102
Total Claims
199,339
Beneficiaries
115
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialSIMPSON, MARK (CEO)
NPI Enumeration Date07/02/2006

Related Entities

Other providers sharing the same authorized official: SIMPSON, MARK

ProviderCityStateTotal Paid
STATE OF WEST VIRGINIA WELCH COMMUNITY HOSPITAL WELCH WV $4.19M
MARK SIMPSON, PC HIXSON TN $19K
MARK SIMPSON PSYD MAC LADC LLC ALBUQUERQUE NM $8K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 33,212 $676K
2019 25,065 $489K
2020 44,455 $1.07M
2021 39,218 $751K
2022 33,082 $549K
2023 37,613 $548K
2024 30,457 $479K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 9,131 7,748 $1.11M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 2,439 1,985 $686K
99283 Emergency department visit for the evaluation and management, moderate severity 4,921 4,402 $331K
80053 Comprehensive metabolic panel 16,271 13,160 $160K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 18,985 15,148 $141K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 9,548 6,456 $137K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2,123 1,948 $122K
74177 Computed tomography, abdomen and pelvis; with contrast material 836 707 $106K
36415 Collection of venous blood by venipuncture 16,228 12,936 $100K
70450 Computed tomography, head or brain; without contrast material 2,031 1,678 $81K
81001 15,829 13,254 $78K
80050 General health panel 2,321 2,039 $77K
71046 Radiologic examination, chest; 2 views 5,727 4,899 $66K
G0378 Hospital observation service, per hour 629 217 $56K
74022 3,013 2,585 $55K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 4,344 3,479 $54K
80305 3,912 3,288 $54K
84484 5,903 4,738 $52K
82805 1,301 982 $52K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 5,224 4,424 $46K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,720 1,550 $46K
87430 3,566 3,075 $45K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 4,821 4,123 $42K
83690 5,229 4,385 $41K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 8,052 6,677 $41K
82150 5,084 4,281 $39K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 628 510 $35K
87088 6,984 5,961 $33K
86318 1,738 1,469 $30K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 79 79 $28K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring 74 71 $28K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 704 626 $28K
85730 4,122 3,468 $25K
96375 Therapeutic injection; each additional sequential IV push 5,064 4,193 $25K
84703 2,298 1,955 $25K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,695 1,400 $24K
99001 1,301 1,092 $24K
86140 5,144 4,247 $23K
85610 4,571 3,774 $23K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1,262 1,010 $21K
87040 1,156 940 $20K
71045 Radiologic examination, chest; single view 2,806 2,300 $20K
83880 1,503 1,189 $20K
74176 Computed tomography, abdomen and pelvis; without contrast material 311 251 $20K
80061 Lipid panel 1,568 1,388 $19K
87086 Culture, bacterial; quantitative colony count, urine 1,990 1,736 $18K
83735 4,138 3,332 $17K
83036 Hemoglobin; glycosylated (A1C) 1,800 1,587 $15K
84436 1,493 1,352 $15K
85379 1,211 1,013 $14K
J7030 Infusion, normal saline solution , 1000 cc 4,532 3,569 $14K
J0696 Injection, ceftriaxone sodium, per 250 mg 5,505 4,262 $13K
84443 Thyroid stimulating hormone (TSH) 682 606 $12K
87070 1,038 848 $12K
71260 Computed tomography, thorax, diagnostic; with contrast material 95 79 $11K
84479 1,136 1,023 $11K
80048 Basic metabolic panel (calcium, ionized) 1,421 1,152 $10K
72110 406 364 $9K
86403 546 466 $7K
73130 241 202 $6K
J1885 Injection, ketorolac tromethamine, per 15 mg 4,723 3,996 $6K
73630 269 235 $5K
83605 544 441 $5K
80320 519 423 $5K
73562 262 226 $5K
94760 54 46 $4K
99281 Emergency department visit for the evaluation and management, self-limited or minor 287 263 $4K
77067 Screening mammography, bilateral, including computer-aided detection 67 63 $4K
73610 239 209 $3K
83518 339 271 $3K
96376 227 154 $3K
84702 213 176 $3K
73030 180 157 $3K
76705 Ultrasound, abdominal, real time with image documentation; limited 77 73 $3K
87075 196 159 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 119 87 $2K
74246 17 15 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 613 521 $2K
84100 109 98 $2K
82553 28 25 $2K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 105 85 $1K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 120 88 $1K
82140 93 68 $1K
72125 Computed tomography, cervical spine; without contrast material 13 12 $1K
73110 96 89 $1K
94664 248 202 $971.81
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 27 25 $895.87
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 39 14 $840.00
80329 243 215 $833.92
J1100 Injection, dexamethasone sodium phosphate, 1 mg 383 304 $707.25
82550 35 30 $658.36
86703 55 54 $643.43
73564 27 26 $590.80
G0463 Hospital outpatient clinic visit for assessment and management of a patient 325 191 $521.00
76830 Ultrasound, transvaginal 13 12 $509.40
J2405 Injection, ondansetron hydrochloride, per 1 mg 1,929 1,566 $498.70
80074 13 12 $471.57
T1015 Clinic visit/encounter, all-inclusive 1,130 501 $438.59
82607 43 38 $399.16
82728 36 34 $360.33
J2175 Injection, meperidine hydrochloride, per 100 mg 67 37 $259.88
73590 15 15 $224.54
L3908 Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf 262 184 $202.70
86803 16 16 $192.60
86900 54 40 $188.94
86886 16 12 $163.89
G0103 Prostate cancer screening; prostate specific antigen test (psa) 19 17 $145.66
J1956 Injection, levofloxacin, 250 mg 35 18 $106.86
74018 14 14 $100.24
84550 16 14 $87.08
86592 15 14 $53.76
J2060 Injection, lorazepam, 2 mg 15 14 $44.85
J2550 Injection, promethazine hcl, up to 50 mg 28 24 $40.42
86901 13 12 $24.21
J2919 Injection, methylprednisolone sodium succinate, 5 mg 32 26 $1.26